5-136029105-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000358.3(TGFBI):āc.50G>Cā(p.Gly17Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,525,908 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000358.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFBI | NM_000358.3 | c.50G>C | p.Gly17Ala | missense_variant | 1/17 | ENST00000442011.7 | NP_000349.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBI | ENST00000442011.7 | c.50G>C | p.Gly17Ala | missense_variant | 1/17 | 1 | NM_000358.3 | ENSP00000416330 | P1 | |
TGFBI | ENST00000504185.5 | n.118G>C | non_coding_transcript_exon_variant | 1/5 | 4 | |||||
TGFBI | ENST00000506699.5 | n.115G>C | non_coding_transcript_exon_variant | 1/17 | 2 | |||||
TGFBI | ENST00000507018.5 | upstream_gene_variant | 5 | ENSP00000421540 |
Frequencies
GnomAD3 genomes AF: 0.000710 AC: 108AN: 152134Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000912 AC: 11AN: 120578Hom.: 0 AF XY: 0.0000150 AC XY: 1AN XY: 66572
GnomAD4 exome AF: 0.0000662 AC: 91AN: 1373658Hom.: 0 Cov.: 31 AF XY: 0.0000443 AC XY: 30AN XY: 677928
GnomAD4 genome AF: 0.000709 AC: 108AN: 152250Hom.: 1 Cov.: 32 AF XY: 0.000645 AC XY: 48AN XY: 74426
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.50G>C (p.G17A) alteration is located in exon 1 (coding exon 1) of the TGFBI gene. This alteration results from a G to C substitution at nucleotide position 50, causing the glycine (G) at amino acid position 17 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
TGFBI-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 31, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at